Abstract

It was found that cadmium telluride (CdTe) quantum dots (QDs) with different sizes can have a great sensitizing effect on chemiluminescence (CL) emission from luminol-potassium periodate (KIO₄) system. Levodopa, a widely prescribed drug in the treatment of Parkinson's disease, could inhibit luminol-KIO₄-CdTe QDs CL reaction in alkaline solution. The inhibited CL intensity was proportional to the concentration of levodopa in the range from 8.0 nM to 10.0 μM. The detection limit was 3.8 nM. This method has been successfully applied to determine levodopa in pharmaceutical preparation and human urine and plasma samples with recoveries of 94.1-105.4%. This was the first work for inhibition effect determination of levodopa using a QD-based CL method.

Comparison of the Absolute Quantum Yields of the Gas-Phase O/NO Reaction and the Liquid-Phase Luminol Oxidation Chemiluminescence Intensity Standards*

Arthur Fontijn and John Lee
J. Opt. Soc. Am. 62(9) 1095-1098 (1972)

Photosensitive cadmium telluride thin-film field-effect transistors

Gwangseok Yang, Donghwan Kim, and Jihyun Kim
Opt. Express 24(4) 3607-3612 (2016)

Wavelength shifting of chemiluminescence using quantum dots to enhance tissue light penetration

Erica A. Mason, Ramona Lopez, and Ralph P. Mason
Opt. Mater. Express 6(4) 1384-1392 (2016)

Dynamic laser-induced effects in nanocomposite systems based on the cadmium sulfide quantum dots in a silicate matrix

S. S. Voznesenskiy, A. A. Sergeev, I. V. Postnova, A. N. Galkina, Yu. A. Shchipunov, and Yu. N. Kulchin
Opt. Express 23(4) 4415-4420 (2015)

Impact of size and shape on trap state controlled luminescence properties of trioctylphosphine-capped cadmium selenide quantum dots

Aditya Nath Bhatt, Upendra Kumar Verma, and Brijesh Kumar
J. Opt. Soc. Am. B 36(6) 1466-1471 (2019)